Dexcom: the bloodbath

In Q2 2024, worldwide sales rose by 15% to $1.004 billion on a reported basis, versus $871.3 million in Q2 2023 and $1.037 billion expected by analyst consensus. Sales in the United States rose by 19%, while international sales increased by 7% on a reported basis and 10% organically, all on a full-y…
© MarketScreener.com 2024